Form 4: United Therapeutics Director Richard Giltner Reports Stock Transactions
SEC Form 4 Filing
Director Richard Giltner reports the vesting of restricted stock units and subsequent conversion into common stock of United Therapeutics.
Summary
- On July 13, 2024, Richard Giltner, a director of United Therapeutics Corp, had 1,800 restricted stock units vest.
- These units were converted on a one-for-one basis into 1,800 shares of common stock.
- The transaction resulted in Giltner directly owning 17,420 shares of common stock following the reported transaction.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in the pharmaceutical industry.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in the director's stock ownership.
Key Dates
| Date | Description |
|---|---|
| 07/13/2024 | Date of transaction: vesting of restricted stock units and conversion to common stock. |
| 07/15/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.